{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:55:05Z","timestamp":1778680505236,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Vessels"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00380-016-0823-0","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T03:23:16Z","timestamp":1456888996000},"page":"1923-1929","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction"],"prefix":"10.1007","volume":"31","author":[{"given":"Takayuki","family":"Mitsuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Uchikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Koyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Iwamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rei","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyoaki","family":"Murohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"823_CR1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"A Schomig","year":"1996","unstructured":"Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini H, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K (1996) A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084\u20131089","journal-title":"N Engl J Med"},{"key":"823_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1253\/circj.67.209","volume":"67","author":"K Sakurai","year":"2003","unstructured":"Sakurai K, Watanabe J, Iwabuchi K, Koseki Y, Kon-no Y, Fukuchi M, Komura T, Shinozaki T, Miura M, Sakuma M, Kagaya Y, Kitaoka S, Shirato K (2003) Comparison of the efficacy of reperfusion therapies for early mortality from acute myocardial infarction in Japan: registry of Miyagi Study Group for AMI (MsAMI). Circ J 67:209\u2013214","journal-title":"Circ J"},{"key":"823_CR3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.amjmed.2004.01.009","volume":"116","author":"RS Taylor","year":"2004","unstructured":"Taylor RS, Brown A, Ebrahim S, Jolliffe J, Noorani H, Rees K, Skidmore B, Stone JA, Thompson DR, Oldridge N (2004) Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116:682\u2013692","journal-title":"Am J Med"},{"key":"823_CR4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","volume":"285","author":"GG Schwartz","year":"2001","unstructured":"Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285:1711\u20131718","journal-title":"JAMA"},{"key":"823_CR5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","volume":"350","author":"CP Cannon","year":"2004","unstructured":"Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495\u20131504","journal-title":"N Engl J Med"},{"key":"823_CR6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.CIR.0000140261.58966.A4","volume":"110","author":"S Okazaki","year":"2004","unstructured":"Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, Daida H (2004) Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation 110:1061\u20131068","journal-title":"Circulation"},{"key":"823_CR7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00380-014-0468-9","volume":"30","author":"T Takayama","year":"2015","unstructured":"Takayama T, Hiro T, Ueda Y, Saito S, Kodama K, KomTakayama T, Hiro T, Ueda Y, Saito S, Kodama K, Komatsu S, Hirayama A (2015) Remodeling pattern is related to the degree of coronary plaque regression induced by pitavastatin: a sub-analysis of the TOGETHER trial with intravascular ultrasound and coronary angioscopy. Heart Vessels 30:169\u2013176","journal-title":"Heart Vessels"},{"key":"823_CR8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","volume":"357","author":"P Barter","year":"2007","unstructured":"Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC (2007) HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 357:1301\u20131310","journal-title":"N Engl J Med"},{"key":"823_CR9","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2015.03.544","volume":"65","author":"GG Schwartz","year":"2015","unstructured":"Schwartz GG, Abt M, Bao W, DeMicco D, Kallend D, Miller M, Mundl H, Olsson AG (2015) Fasting triglycerides predict recurrent ischemic events in patients with acute coronary syndrome treated with statins. J Am Coll Cardiol 65:2267\u20132275","journal-title":"J Am Coll Cardiol"},{"key":"823_CR10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/ATVBAHA.108.178947","volume":"29","author":"NS Jenny","year":"2009","unstructured":"Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM (2009) Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 29:594\u2013599","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"823_CR11","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.ATV.0000144010.55563.63","volume":"24","author":"L Berglund","year":"2004","unstructured":"Berglund L, Ramakrishnan R (2004) Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 24:2219\u20132226","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"823_CR12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/clc.4960270503","volume":"27","author":"A Deb","year":"2004","unstructured":"Deb A, Caplice M (2004) Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis. Clin Cardiol 27:258\u2013264","journal-title":"Clin Cardiol"},{"key":"823_CR13","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00380-013-0346-x","volume":"29","author":"M Nishino","year":"2014","unstructured":"Nishino M, Mori N, Yoshimura T, Nakamura D, Lee Y, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y (2014) Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm. Heart Vessels 29:186\u2013190","journal-title":"Heart Vessels"},{"key":"823_CR14","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","volume":"301","author":"PR Kamstrup","year":"2009","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG (2009) Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301:2331\u20132339","journal-title":"JAMA"},{"key":"823_CR15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","volume":"64","author":"P Willeit","year":"2014","unstructured":"Willeit P, Kiechl S, Kronenberg F, Witztum JL, Santer P, Mayr M, Xu Q, Mayr M, Willeit J, Tsimikas S (2014) Discrimination and net reclassification of cardiovascular risk with lipoprotein(a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol 64:851\u2013860","journal-title":"J Am Coll Cardiol"},{"key":"823_CR16","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1161\/ATVBAHA.112.255521","volume":"32","author":"D Gurdasani","year":"2012","unstructured":"Gurdasani D, Sjouke B, Tsimikas S, Hovingh GK, Luben RN, Wainwright NW, Pomilla C, Wareham NJ, Khaw KT, Boekholdt SM, Sandhu MS (2012) Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 32:3058\u20133065","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"823_CR17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","volume":"129","author":"AV Khera","year":"2014","unstructured":"Khera AV, Everett BM, Caulfield MP, Hantash FM, Wohlgemuth J, Ridker PM, Mora S (2014) Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin). Circulation 129:635\u2013642","journal-title":"Circulation"},{"key":"823_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0002-9343(00)00652-5","volume":"110","author":"M Seed","year":"2001","unstructured":"Seed M, Ayres KL, Humphries SE, Miller GJ (2001) Lipoprotein(a) as a predictor of myocardial infarction in middle-aged men. Am J Med 110:22\u201327","journal-title":"Am J Med"},{"key":"823_CR19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classifications of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539\u2013553","journal-title":"Diabet Med"},{"key":"823_CR20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"823_CR21","first-page":"575","volume-title":"Principles and Practice of echocardiography","author":"C Vuille","year":"1994","unstructured":"Vuille C, Weyman AE (1994) Left ventricle I general considerations, assessment of chamber size and function. Principles and Practice of echocardiography, 2nd edn. Lea & Febiger, Philadelphia, pp 575\u2013624","edition":"2"},{"key":"823_CR22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.jacc.2012.04.038","volume":"60","author":"S Tsimikas","year":"2012","unstructured":"Tsimikas S, Hall JL (2012) Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies. J Am Coll Cardiol 60:716\u2013721","journal-title":"J Am Coll Cardiol"},{"key":"823_CR23","doi-asserted-by":"crossref","first-page":"23260","DOI":"10.1074\/jbc.M302780200","volume":"278","author":"MA Hancock","year":"2003","unstructured":"Hancock MA, Boffa MB, Marcovina SM, Nesheim ME, Koschinsky ML (2003) Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces. J Biol Chem 278:23260\u201323269","journal-title":"J Biol Chem"},{"key":"823_CR24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/360670a0","volume":"360","author":"RM Lawn","year":"1992","unstructured":"Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM (1992) Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 360:670\u2013672","journal-title":"Nature"},{"key":"823_CR25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.ATV.18.4.641","volume":"18","author":"LB Nielsen","year":"1998","unstructured":"Nielsen LB, Juul K, Nordestgaard BG (1998) Increased degradation of lipoprotein(a) in atherosclerotic compared with nonlesioned aortic intima-inner media of rabbits: in vivo evidence that lipoprotein(a) may contribute to foam cell formation. Atheroscler Thromb Vasc Biol 18:641\u2013649","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"823_CR26","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1161\/ATVBAHA.113.302479","volume":"33","author":"PJ Nestel","year":"2013","unstructured":"Nestel PJ, Barnes EH, Tonkin AM, Simes J, Fournier M, White HD, Colquhoun DM, Blankenberg S, Sullivan DR (2013) Plasma lipoprotein(a) concentration predicts coronary and cardiovascular events in patients with stable coronary heart disease. Atheroscler Thromb Vasc Biol 33:2902\u20132908","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"823_CR27","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1253\/circj.CJ-11-0365","volume":"75","author":"H Ikenaga","year":"2011","unstructured":"Ikenaga H, Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Miura F, Nakama Y, Dai K, Otani T, Ejiri K, Oda N, Nakamura M, Miki T (2011) Usefulness of Lipoprotein(a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction. Circ J 75:2847\u20132852","journal-title":"Circ J"},{"key":"823_CR28","first-page":"77","volume":"43","author":"M Motta","year":"2001","unstructured":"Motta M, Giugno I, Bosco S, Pistone G, Ruello P, Maugeri D, Malaguarnera M (2001) Serum lipoprotein(a) changes in acute myocardial infarction. Panminerva Med 43:77\u201380","journal-title":"Panminerva Med"},{"key":"823_CR29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.amjcard.2014.10.015","volume":"115","author":"H Konishi","year":"2015","unstructured":"Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R, Sai E, Fukushima Y, Katoh Y, Okai I, Tamura H, Okazaki S, Daida H (2015) Impact of lipoprotein(a) as residual risk on long-term outcomes in patients after percutaneous coronary intervention. Am J Cardiol 115:157\u2013160","journal-title":"Am J Cardiol"},{"key":"823_CR30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jacc.2012.12.023","volume":"61","author":"PR Kamstrup","year":"2013","unstructured":"Kamstrup PR, Tybjaerg-Hansen A, Nordestgaard BG (2013) Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 61:1146\u20131156","journal-title":"J Am Coll Cardiol"},{"key":"823_CR31","first-page":"2499","volume":"307","author":"E Angelantonio Di","year":"2012","unstructured":"Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundstrom J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G, D\u2019Agostino RB Sr, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gomez-de-la-Camara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J (2012) Lipid-related markers and cardiovascular disease prediction. JAMA 307:2499\u20132506","journal-title":"JAMA"},{"key":"823_CR32","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.jacc.2013.06.051","volume":"62","author":"JJ Albers","year":"2013","unstructured":"Albers JJ, Slee A, O\u2019Brien KD, Robinson JG, Kashyap ML, Kwiterovich PO Jr, Xu P, Marcovina SM (2013) Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (atherothrombosis intervention in metabolic syndrome with low HDL\/High triglyceride and impact on global health outcomes). J Am Coll Cardiol 62:1575\u20131579","journal-title":"J Am Coll Cardiol"},{"key":"823_CR33","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.283.14.1845","volume":"283","author":"MG Shlipak","year":"2000","unstructured":"Shlipak MG, Simon JA, Vittinghoff E, Lin F, Barrett-Connor E, Knopp RH, Levy RI, Hulley SB (2000) Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. JAMA 283:1845\u20131852","journal-title":"JAMA"},{"key":"823_CR34","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1316222","volume":"370","author":"DJ Blom","year":"2014","unstructured":"Blom DJ, Hala T, Bolognese M, Lillestol MJ, Toth PD, Burgess L, Ceska R, Roth E, Keren MJ, Ballantyne CM, Monsalvo ML, Tsirtsonis K, Kim JB, Scott R, Wasserman SM, Stein EA (2014) A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med 370:1809\u20131819","journal-title":"N Engl J Med"},{"key":"823_CR35","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","volume":"386","author":"S Tsimikas","year":"2015","unstructured":"Tsimikas S, Viney NJ, Hughes SG, Singleton W, Graham MJ, Baker BF, Burkey JL, Yang Q, Marcovina SM, Geary RS, Crooke RM, Witztum JL (2015) Antisense therapy targeting apolipoprotein(a): a randomized, double-blind, placebo-controlled phase 1 study. Lancet 386:1472\u20131483","journal-title":"Lancet"}],"container-title":["Heart and Vessels"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00380-016-0823-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00380-016-0823-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:27:53Z","timestamp":1559042873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00380-016-0823-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1007\/s00380-016-0823-0","relation":{},"ISSN":["0910-8327","1615-2573"],"issn-type":[{"value":"0910-8327","type":"print"},{"value":"1615-2573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}